Lindbrook Capital’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$96.2K Sell
9,350
-5
-0.1% -$49 0.01% 694
2024
Q4
$89.2K Buy
9,355
+1,724
+23% +$16.9K 0.01% 589
2024
Q3
$80.7K Buy
7,631
+939
+14% +$9.08K 0.01% 630
2024
Q2
$55.3K Buy
6,692
+75
+1% +$627 0.01% 750
2024
Q1
$56.2K Sell
6,617
-763
-10% -$6.38K 0.01% 740
2023
Q4
$60.7K Buy
7,380
+22
+0.3% +$181 0.01% 691
2023
Q3
$61.3K Buy
7,358
+41
+0.6% +$341 0.01% 610
2023
Q2
$61.3K Buy
7,317
+340
+5% +$2.9K 0.01% 636
2023
Q1
$56.8K Buy
6,977
+306
+5% +$2.44K 0.01% 651
2022
Q4
$53.4K Buy
6,671
+2,882
+76% +$19.6K 0.01% 668
2022
Q3
$23K Buy
+3,789
New +$24.5K ﹤0.01% 926

Other funds holding HLN

Lindbrook Capital's HLN Position: Q1 2025 in Review

Lindbrook Capital reduced its Haleon (HLN) stake by 0.05% in Q1 2025, selling an estimated $49 and leaving 9,350 shares worth $96.2K. The position accounts for 0.01% of the portfolio, ranked #694.

Lindbrook Capital first reported a position in HLN in Q3 2022 and has held it in 11 quarters since. 598 funds tracked by Wall St. Rank hold HLN as of Q1 2025.

  • Lindbrook Capital held 9,350 shares of Haleon worth $96.2K as of Q1 2025.
  • Lindbrook Capital sold 5 Haleon shares in Q1 2025, an estimated $49.
  • Haleon made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #694 holding.
  • Lindbrook Capital first reported a position in Haleon in Q3 2022 and has held it in 11 quarters since.
  • 598 funds tracked by Wall St. Rank held Haleon as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.